Investor Presentaiton

Strategic Plan Targets: 2026 Goals Focused on driving RMS profitable revenue growth DSA Charles River Laboratories (CRL) 2026 Financial Targets Organic Revenue Growth (2023-26E CAGR) Non-GAAP Operating Margin (2026E) 6%-8% Mid- to high-20% range 6%-8% Mid- to high-20% range Above 30% Manufacturing ~10% Consolidated 6%-8% ~150 bps of cumulative improvement from 2023 17

View entire presentation